Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 1COV.DE
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Bad
0%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 1.00 1.78 1.77
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -60.14 10.20 25.60
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.44 35.07 34.92
Cash 16.77 3.95 3.38
Capex 65.13 -0.56 -1.61
Free Cash Flow 452.00 -0.73 0.13
Revenue 4.90 18.60 17.73
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 33.28 0.17 0.13
Operating Margin -51.50 0.02 -0.03
ROA 81.02 < 0.005 -0.01
ROE 81.37 < 0.005 -0.03
ROIC 71.40 < 0.005 -0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 1COV.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 1COV.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 1COV.DE is permitted for members.